19980302
 Health Brief -- HUMAN GENOME SCIENCES INC.: Collaboration Deal Agreed To With French Company   The Wall Street Journal,  Mar 3, 1998  In an effort to turn its gene-discovery technology into revenue-producing therapies, Human Genome Sciences Inc, Rockville MD, has agreed to develop new gene-therapy treatments in a 10-year collaboration with the French biotechnology company Transgene Inc. Genome will receive a 10% stake in Transgene, which plans to make an initial public offering soon.   
